#update
Collection of update news, found 1.127 news.
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- Market fundamentals remain strong; Catastrophe-exposed risks faced tougher ...
A disgruntled employee killed two people at a California quarry and injured seven in two separate shootings Wednesday, ...
Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast
- March 2011 Data Confirm Strong Treatment Effect of ...
Largest Ever Epidemiological Survey in Chronic Venous Disease Including 70, 000 Patients Shows the I
- - "Early Diagnosis and Treatment of Chronic Venous Disease are Mandatory to Prevent ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w
- In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...
Largest International Registry of Stable Coronary Artery Disease Shows That Many Patients Have too H
- Results from CLARIFY, the largest international registry ever ...
- Leading carry solutions brand DICOTA is gearing up for IFA, the global trade ...
Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido
-Analysis evaluated efficacy and safety among three patient sub-groups A new ...
- Increasing its Technical Expertise in Asia Avnet, Inc. (NYSE:AVT) announced today ...
- Strengthens Leadership Position in Asia IP&E Market Avnet, Inc. (NYSE:AVT) ...
Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
- Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...
- Blood Tests Still Necessary for Latent Disease; WHO Guidance is Not Applicable to ...
Eleven more people died of cholera last week in Dominican Republic, bringing the death toll to 87, the Health Ministry ...